IceCure Medical (ICCM) to Release Quarterly Earnings on Tuesday

IceCure Medical (NASDAQ:ICCM) is set to announce its earnings results before the market opens on Tuesday, August 20th. Analysts expect the company to announce earnings of ($0.07) per share for the quarter.

IceCure Medical (NASDAQ:ICCM) last released its quarterly earnings results on Tuesday, May 28th. The company reported ($0.08) EPS for the quarter, meeting analysts’ consensus estimates of ($0.08). IceCure Medical had a negative return on equity of 101.66% and a negative net margin of 444.30%. The company had revenue of $0.74 million during the quarter, compared to analysts’ expectations of $0.80 million. During the same period last year, the business posted ($0.08) earnings per share. On average, analysts expect IceCure Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

IceCure Medical Stock Performance

ICCM opened at $0.61 on Wednesday. The company has a market cap of $28.01 million, a P/E ratio of -1.86 and a beta of 0.57. The company has a quick ratio of 2.88, a current ratio of 3.39 and a debt-to-equity ratio of 0.03. The firm’s 50-day moving average price is $0.73 and its 200-day moving average price is $1.06. IceCure Medical has a 52-week low of $0.52 and a 52-week high of $1.57.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and set a $3.00 price objective on shares of IceCure Medical in a research note on Tuesday, July 2nd.

IceCure Medical Company Profile

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.